Home | Meniscusprothesis ATRO Medical receives FDA breakthrough Designation
Meniscusprothesis ATRO Medical receives FDA breakthrough Designation
Home | Meniscusprothesis ATRO Medical receives FDA breakthrough Designation
Meniscusprothesis ATRO Medical receives FDA breakthrough Designation
Jan Hunik, CEO of ATRO Medical, states: “We’re looking forward to the intensified collaboration with FDA and are convinced that…
Jan Hunik, CEO of ATRO Medical, states: "We're looking forward to the intensified collaboration with FDA and are convinced that this will speed up our access to the US market."
Read the full version of this article on the website of Radboudumc.
